Risk factors of new-onset glucose abnormalities in idiopathic membranous nephropathy patients on glucocorticoid plus tacrolimus
Objective To explore the risk factors for new-onset glucose abnormalities in patients of idiopathic membranous nephropathy (IMN) on glucocorticoid plus tacrolimus. Methods From August 2019 to January 2022, 118 patients with a diagnosis of IMN via renal biopsy were recruited from First Affiliated Hos...
Saved in:
Main Authors: | Jin Li (Author), Hui-shu Han (Author), Shu-long Wang (Author), Yan Bao (Author), Yi-qun Peng (Author) |
---|---|
Format: | Book |
Published: |
Editorial Department of Journal of Clinical Nephrology,
2023-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
New-Onset Diabetes Mellitus in Patients with Idiopathic Membranous Nephropathy Undergoing Tacrolimus and Low-Dose Corticosteroid Therapy
by: Lina Shao, et al.
Published: (2019) -
Efficacy of tacrolimus plus glucocorticoid for lupus nephritis: a Meta-analysis
by: Yi-xi Xing, et al.
Published: (2024) -
Efficacy and safety of tacrolimus vs cyclophosphamide in the therapy of patients with idiopathic membranous nephropathy: a meta-analysis
by: Lin W, et al.
Published: (2019) -
Effects of CYP3A5 Polymorphisms on Efficacy and Safety of Tacrolimus Therapy in Patients with Idiopathic Membranous Nephropathy
by: Zhang C, et al.
Published: (2020) -
Advances in Pathogenesis of Idiopathic Membranous Nephropathy
by: Zhifeng Xu, et al.
Published: (2020)